Trulieve Cannabis Corp. to Uplist to NYSE
Trulieve Cannabis Corp. is set to uplist its subordinate voting shares to the New York Stock Exchange (NYSE) under the ticker symbol "TRLV," with trading commencing on Wednesday, June 10. The company, a prominent medical cannabis provider, makes this move to enhance its visibility and access to capital markets. In a separate development, CAE Inc. has received regulatory approval to renew its normal course issuer bid, allowing it to repurchase up to 16,073,033 of its common shares for cancellation. This share buyback program is scheduled to run from June 10, 2026, to June 9, 2027.